dexmethylphenidate hydrochloride has been researched along with atomoxetine hydrochloride in 4 studies
| Studies (dexmethylphenidate hydrochloride) | Trials (dexmethylphenidate hydrochloride) | Recent Studies (post-2010) (dexmethylphenidate hydrochloride) | Studies (atomoxetine hydrochloride) | Trials (atomoxetine hydrochloride) | Recent Studies (post-2010) (atomoxetine hydrochloride) |
|---|---|---|---|---|---|
| 65 | 27 | 22 | 1,386 | 306 | 788 |
| Protein | Taxonomy | dexmethylphenidate hydrochloride (IC50) | atomoxetine hydrochloride (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Findling, RL | 1 |
| Kratochvil, CJ; May, DE | 1 |
| Bussing, R; Kubilis, P; Liu, X; Winterstein, AG | 1 |
| Avillach, P; Feroe, AG; Greenspun, P; Gutiérrez-Sacristán, A; Kohane, IS; Mousavi, S; Surati, R; Uppal, N | 1 |
1 review(s) available for dexmethylphenidate hydrochloride and atomoxetine hydrochloride
| Article | Year |
|---|---|
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dexmethylphenidate Hydrochloride; Humans; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Prodrugs; Propylamines | 2008 |
3 other study(ies) available for dexmethylphenidate hydrochloride and atomoxetine hydrochloride
| Article | Year |
|---|---|
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Half-Life; Health Care Costs; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Pediatrics; Prodrugs; Propylamines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Development of a refill pattern method to measure polypharmacy in administrative claims databases.
Topics: Adolescent; Algorithms; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Databases, Factual; Dexmethylphenidate Hydrochloride; Female; Humans; Male; Methylphenidate; Pharmacoepidemiology; Polypharmacy; Time Factors | 2016 |
Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Bupropion; Child; Child, Preschool; Cohort Studies; Comorbidity; Data Mining; Depressive Disorder, Major; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Female; Health Services Accessibility; Humans; Insurance; Lisdexamfetamine Dimesylate; Male; Managed Care Programs; Prevalence; Retrospective Studies | 2021 |